These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12506689)

  • 1. Neuroprotective effect of naloxone in inflammation-mediated dopaminergic neurodegeneration. Dissociation from the involvement of opioid receptors.
    Liu B; Hong JS
    Methods Mol Med; 2003; 79():43-54. PubMed ID: 12506689
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition by naloxone stereoisomers of beta-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons.
    Liu Y; Qin L; Wilson BC; An L; Hong JS; Liu B
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1212-9. PubMed ID: 12183682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation.
    Liu B; Du L; Hong JS
    J Pharmacol Exp Ther; 2000 May; 293(2):607-17. PubMed ID: 10773035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids inhibit dopamine secretion from PC12 rat pheochromocytoma cells in a naloxone-reversible manner.
    Venihaki M; Gravanis A; Margioris AN
    Life Sci; 1996; 58(1):75-82. PubMed ID: 8628113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide.
    Liu B; Jiang JW; Wilson BC; Du L; Yang SN; Wang JY; Wu GC; Cao XD; Hong JS
    J Pharmacol Exp Ther; 2000 Oct; 295(1):125-32. PubMed ID: 10991969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression.
    Mavridis M; Besson MJ
    Neuroscience; 1999; 92(3):945-66. PubMed ID: 10426535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of hibernation-regulating substances against low-temperature-induced cell death in cultured hamster hippocampal neurons.
    Tamura Y; Monden M; Shintani M; Kawai A; Shiomi H
    Brain Res; 2006 Sep; 1108(1):107-16. PubMed ID: 16854391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of dopamine autoreceptors in the reactive effect of opioid antagonists].
    Dubrovina NI
    Biull Eksp Biol Med; 1995 Feb; 119(2):120-4. PubMed ID: 7670029
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopaminergic mechanisms involved in prolactin release after mifepristone and naloxone treatment during late pregnancy in the rat.
    Soaje M; Valdez S; Bregonzio C; Penissi A; Deis RP
    Neuroendocrinology; 2006; 84(1):58-67. PubMed ID: 17090971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium attenuates pain-related behavior in a rat model of neuropathic pain: possible involvement of opioid system.
    Banafshe HR; Mesdaghinia A; Arani MN; Ramezani MH; Heydari A; Hamidi GA
    Pharmacol Biochem Behav; 2012 Jan; 100(3):425-30. PubMed ID: 22009032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence.
    Makimura M; Sugimoto H; Shinomiya K; Kabasawa Y; Fukuda H
    J Toxicol Sci; 1996 May; 21(2):135-41. PubMed ID: 8780997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
    Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR
    Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
    Tian YY; An LJ; Jiang L; Duan YL; Chen J; Jiang B
    Life Sci; 2006 Dec; 80(3):193-9. PubMed ID: 17049947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone does not alter amphetamine-induced rotational behavior or striatal dopamine levels of nigrally-lesioned rats.
    Kimmel HL; Schad CA; Justice JB; Holtzman SG
    Brain Res; 1998 Apr; 789(1):171-4. PubMed ID: 9602114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of dopaminergic receptor signaling in the effects of glutamatergic receptor antagonists on conditioned place aversion induced by naloxone in single-dose morphine-treated rats.
    Kawasaki Y; Araki H; Suemaru K; Kitamura Y; Gomita Y; Sendo T
    J Pharmacol Sci; 2011; 117(1):27-33. PubMed ID: 21821972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems.
    Samadi P; Grégoire L; Bédard PJ
    Neuropharmacology; 2003 Dec; 45(7):954-63. PubMed ID: 14573388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of Specific Involvement of (+)-Naloxone and (+)-Naltrexone on the Reinforcing and Neurochemical Effects of Cocaine and Opioids.
    Tanda G; Mereu M; Hiranita T; Quarterman JC; Coggiano M; Katz JL
    Neuropsychopharmacology; 2016 Oct; 41(11):2772-81. PubMed ID: 27296151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid peptides alleviated while naloxone potentiated methamphetamine-induced striatal dopamine depletion in mice.
    Yu L; Kuo YM; Cherng CF
    J Neural Transm (Vienna); 2001; 108(11):1231-7. PubMed ID: 12030189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors.
    French ED
    Neurosci Lett; 1997 May; 226(3):159-62. PubMed ID: 9175591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.